论文部分内容阅读
噻唑烷二酮类(thiazolidinediones,TDZs)激活核受体过氧化物酶增殖剂激活受体-γ(peroxisome proliferator-activated recep-tor-γ,PPAR-γ),提高胰岛素敏感性,长期用于治疗2型糖尿病。但其同时有增加患者体重的副作用。此前的研究表明,大脑
Thiazolidinediones (TDZs) activate the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPAR-gamma), increase insulin sensitivity and are used for long-term treatment Type 2 diabetes. But at the same time it increases the side effects of the patient’s weight. Previous studies have shown that the brain